End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.85 EUR | -.--% |
|
+1.19% | -58.33% |
Jul. 12 | BIOPHYTIS : Invest Securities confirms its recommendation | CF |
Jul. 11 | Biophytis Secures US FDA Approval for Mid-stage Study of Obesity Drug | MT |
Chart calendar Biophytis S.A.
Upcoming events on Biophytis S.A.
Past events on Biophytis S.A.
2024-06-24 08:00 am | Shareholders Meeting |
2024-04-08 05:00 am | Q4 2023 Earnings Release |
2024-04-01 | Extraordinary Shareholders Meeting |
2024-03-19 | ICFSR Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,00 | 0,00 | 0,00 2,80 - | 0,00 0,00 - | 0,00 |
EBITDA Million EUR | Released Forecast Spread | 0,00 | 0,00 | -22,8 -23,3 2.2% | -13,5 -14,5 6.69% | -14,8 |
EBIT Million EUR | Released Forecast Spread | 0,00 | -26,8 | -23,3 -23,3 0.12% | -14,3 -14,5 1.15% | -14,8 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,00 | -31,2 | -24,2 -32,5 25.49% | -17,0 -18,5 7.97% | -19,8 |
Net income Million EUR | Released Forecast Spread | -17,1 | -31,2 | -24,2 -32,5 25.49% | -17,0 -18,5 7.97% | -19,8 |
EPS EUR | Released Forecast Spread | -112 | -104 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
Announcement Date | 12/03/21 | 07/04/22 | 19/04/23 | 08/04/24 | - |
Quarterly results
Fiscal Period | December | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 2,80 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | |
EBITDA Million EUR | Released Forecast Spread | -11,8 11,5 -202.35% | -11,0 -11,7 5.83% | -6,27 -13,1 52.15% | -7,26 -8,00 9.23% | -6,50 | -8,30 | ||
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -18,0 | -12,4 -15,9 22.03% | -11,8 -16,6 28.81% | -7,76 -15,1 48.58% | -9,26 -10,8 14.24% | -7,80 | -12,1 | |
Net income Million EUR | Released Forecast Spread | -15,9 | -18,0 | -12,4 -15,9 22.03% | -11,8 -16,6 28.81% | -7,76 -15,1 48.58% | -9,26 -10,8 14.24% | -7,80 | -12,1 |
EPS EUR | Released Forecast Spread | -56,0 | -56,0 | -32,0 -48,0 33.33% | |||||
Announcement Date | 17/09/21 | 07/04/22 | 31/01/23 | 19/04/23 | 27/09/23 | 08/04/24 | - | - |
Past sector events for Biophytis S.A.
2024-07-11 04:00 pm | NURIX THERAPEUTICS, INC.: Q2 2024 Earnings Release |
2024-07-04 | PHARMAESSENTIA CORPORATION: June 2024 Sales and Revenue Release |
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALBPS Stock
- ALBPS Stock
- Calendar Biophytis S.A.